Advent Life Sciences

Status

ACTIVE

Global HQ

Washington, United Kingdom

Countries of investment

United Kingdom
USA
France
Denmark
Finland
Norway
Sweden
Germany
Netherlands
Switzerland
Austria
Czech Republic
Slovakia
Hungary
Poland
Romania
Bulgaria
Croatia
Slovenia
Estonia
Latvia
Lithuania
Malta
Moldova
Ukraine
Spain
Portugal
Italy
Greece
Cyprus

Investment stages

Seed
Series A
Series B

Industries

Biotechnology
Life Sciences
MedTech

About
Advent Life Sciences is a trans-Atlantic venture capital firm focused on building innovative life sciences businesses in the UK, Europe, and the USA. The firm invests early and mid-stage in pioneering drug discovery across modalities, med tech, enabling technologies, and vaccines. Advent operates with a hands-on approach, partnering closely with management teams to transform breakthrough science into approved medicines or medical products.

Min check size: $1M
Max check size: $50M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Advent Life Sciences is a venture capital firm focused on life sciences, investing across therapeutics, medical devices, and diagnostics. The firm partners with pioneering scientists and entrepreneurs to support breakthroughs that address unmet medical needs.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Advent Life Sciences is a leading trans-Atlantic venture capital firm focused on building innovative life sciences businesses in the UK, Europe, and the USA. They invest early and mid-stage in companies with first-in-class or best-in-class approaches across new drug discovery, med tech, enabling technologies, and vaccines. Their hands-on team works closely with management to bring breakthrough science to approved medicines and products.